Evidence map›Paper›PMID 39288373›Full record

ArticleJMIR research protocols2024

Peer Intervention to Link Overdose Survivors to Treatment (PILOT): Protocol for a Multisite, Randomized Controlled Trial Conducted Within the National Institute on Drug Abuse Clinical Trials Network.

Carrie Papa, Erin A McClure, Jenna McCauley, Louise Haynes, Timothy Matheson, Richard Jones, Lindsey Jennings, Tricia Lawdahl, Ralph Ward, Kathleen Brady and 1 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in JMIR research protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05123027 (NIDA CTN-0107 Peer Intervention to Link Overdose Survivors to Treatment), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05123027 nacompletednot on this map

NIDA CTN-0107 Peer Intervention to Link Overdose Survivors to Treatment (PILOT)

TypeinterventionalSponsorMedical University of South CarolinaRan2021 to 2024Enrolled150ConditionsOpioid OverdoseArmsPeer Intervention to Link Overdose Survivors to Treatment (PILOT) Peer, Treatment As Usual Peer
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Carrie PapaDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States.ORCID 0000-0002-8761-6144
Erin A McClureDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States.ORCID 0000-0001-9744-7818
Jenna McCauleyDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States.ORCID 0000-0001-8406-2329
Louise HaynesDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States.ORCID 0000-0002-8032-3525
Timothy MathesonSan Francisco Department of Public Health, San Francisco, CA, United States.ORCID 0000-0002-6394-5963
Richard JonesHeritage Health Solutions, Coppell, TX, United States.ORCID 0009-0007-2979-9476
Lindsey JenningsDepartment of Emergency Medicine, Medical University of South Carolina, Charleston, SC, United States.ORCID 0000-0002-9462-0424
Tricia LawdahlFaces and Voices of Recovery - Upstate South Carolina, Greenville, SC, United States.ORCID 0000-0002-2858-7910
Ralph WardDepartment of Public Health Sciences, Medical University of South Carolina, Charleston, SC, United States.ORCID 0000-0001-6193-2838
Kathleen BradyDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States.ORCID 0000-0002-3944-8051
Kelly Stephenson BarthDepartment of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States.ORCID 0000-0001-6339-6573

Funding

South Carolina Clinical & Translational Research Institute (SCTR)UL1TR001450 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T., FLUME, PATRICK A · 2015 to 2024
$41.1M
Southern Consortium Node of the Clinical Trials Network (Varenicline)UG1DA013727 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KATHLEEN T. BRADY, Kelly S. Barth · 2015 to 2026
$24.8M
NCATS NIH HHS UL1 TR001450NIDA NIH HHS UG1 DA013727
6 · The paper itself

Abstract

backgroundThe increase in opioid-related overdoses has caused a decrease in average life expectancy, highlighting the need for effective interventions to reduce overdose risk and prevent subsequent overdoses. Peer support specialists (PSSs) offer an appealing strategy to engage overdose survivors and reduce overdose risk, but randomized controlled trials are needed to formalize peer-led interventions and evaluate their effectiveness.

objectiveThis National Institute on Drug Abuse Clinical Trials Network (CTN) study is a multisite, prospective, pilot randomized (1:1) controlled trial (CTN protocol 0107) that aims to evaluate the effectiveness of an emergency department (ED)-initiated, peer-delivered intervention tailored for opioid overdose survivors (Peer Intervention to Link Overdose survivors to Treatment [PILOT]), compared with treatment as usual (TAU).

methodsThis study evaluates the effectiveness of the 6-month, PSS-led PILOT intervention compared with TAU on the primary outcome of reducing overdose risk behavior 6 months after enrollment. Adults (aged ≥18 years; N=150) with a recent opioid-related overdose were identified and approached in the ED. Participants were screened and enrolled, either in the ED or within 7 days of ED discharge at research offices or in the community and then asked to complete study visits at months 1, 3, 6 (end of intervention), and 7 (follow-up). Participants were enrolled at 3 study sites in the United States: Greenville, South Carolina; Youngstown, Ohio; and Everett, Washington. Participants randomized to the PILOT intervention received a 6-month, PSS-led intervention tailored to each participant's goals to reduce their overdose risk behavior (eg, overdose harm reduction, housing, medical, and substance use treatment or recovery goals). Participants randomized to TAU received standard-of-care overdose materials, education, and services provided through the participating EDs. This paper describes the study protocol and procedures, explains the design and inclusion and exclusion decisions, and provides details of the peer-led PILOT intervention and supervision of PILOT PSSs.

resultsStudy enrollment opened in December 2021 and was closed in July 2023. A total of 150 participants across 3 sites were enrolled in the study, meeting the proposed sample size for the trial. Primary and secondary analyses are underway and expected to be published in early 2025.

conclusionsThere is an urgent need to better understand the characteristics of overdose survivors presenting to the ED and for rigorous trials evaluating the effectiveness of PSS-led interventions on engaging overdose survivors and reducing overdose risk. Results from this pilot randomized controlled trial will provide a description of the characteristics of overdose survivors presenting to the ED; outline the implementation of PSS services research in ED settings, including PSS implementation of PSS supervision and activity tracking; and inform ED-initiated PSS-led overdose risk reduction interventions and future research to better understand the implementation and efficacy of these interventions.

trial registrationClinicalTrials.gov NCT05123027; https://clinicaltrials.gov/study/NCT05123027. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/60277.

Indexed as

Drug OverdosePeer GroupAdultEmergency Service, HospitalFemaleHumansMaleMulticenter Studies as TopicPilot ProjectsProspective StudiesRandomized Controlled Trials as TopicSurvivorsUnited Statesemergency departmentharm reductionnonfatal overdose involving opioidsopioidsoverdosepeer support specialist

Identifiers

PMID39288373
PMCPMC11445628

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.